Spectral Medical Inc.
EDTXF
$0.96
$0.011.30%
OTC PK
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 133.83% | -44.09% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 133.83% | -44.09% | |||
| Cost of Revenue | 47.44% | -43.07% | |||
| Gross Profit | 232.81% | -45.22% | |||
| SG&A Expenses | 57.59% | -22.15% | |||
| Depreciation & Amortization | -24.45% | 6.23% | |||
| Other Operating Expenses | -52.65% | 132.04% | |||
| Total Operating Expenses | 50.78% | -21.81% | |||
| Operating Income | -37.32% | 16.41% | |||
| Income Before Tax | -3.71% | 90.75% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -3.71% | 90.75% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -3.82% | 90.75% | |||
| EBIT | -37.32% | 16.41% | |||
| EBITDA | -37.90% | 16.41% | |||
| EPS Basic | -2.86% | 90.87% | |||
| Normalized Basic EPS | -215.38% | 107.57% | |||
| EPS Diluted | -2.86% | 90.87% | |||
| Normalized Diluted EPS | -215.38% | 107.57% | |||
| Average Basic Shares Outstanding | 0.51% | 1.67% | |||
| Average Diluted Shares Outstanding | 0.51% | 1.67% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||